Abstract
The number of endogenous mediators of inflammation is large and growing, but the list of endogenous inhibitors of inflammation has remained relatively small. Most investigators are familiar with glucocorticoids, and there is an increasing appreciation of lipid mediators, select cytokines, and endogenous cytokine inhibitors as anti-inflammatory mediators. Adenosine, a purine nucleoside, is another agent that has received increasing interest as an endogenous anti-inflammatory agent. In this chapter the author will discuss the generation of adenosine at inflamed sites, the cell surface receptors for adenosine, which, when occupied, affect inflammatory cell function and the functional effects of adenosine on the various inflammatory cells and the inflammatory process. Finally, the author will discuss the potential pharmacologic uses of adenosine as an anti-inflammatory agent.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pearson, J. D. and Gordon, J. L. (1979) Vascular endothelial and smooth muscle cells in culture selectively released adenine nucleotides. Nature 281, 384–386.
Kitakaze, M., Hori, M., Morioka, T., Takashima, S., Minamino, T., Sato, H., Inoue, M., and Kamada, T. (1993) Attenuation of ecto-5′-nucleotidase activity and adenosine release in activated human polymorphonuclear leuLocytes. Circ. Res. 73, 524–533.
Node, K., Kitakaze, M., Minamino, T., Tasa, M., Inoue, M., Nori, M., and Kamsda, T. (1997) Activation of ecto-5′-nucleotidase by protein kinase and its role in ischaemic tolerance in the canine head. Br. J. Pharmacol. 120, 273–281.
Van Belle, H. (1993) Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? Cardiovasc. Res. 27, 68–76.
Resta, R., Hooker, S. W., Laurent, A. B., Jamshedur, S. M., Rahman, Franklin, M., Knudsen, T. B., Nadon, N. L., and Thompson, L. F. (1997) Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5′-nucleoti-dase (CD73). J. Clin. Invest. 99(4), 676–683.
van Waeg, G. and Van den Berghe, G. (1991) Purine catabolism in polymorphonuclear neutrophils: Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase. J. Clin. Invest. 87, 305–312.
Drury, A. N. and Szent-Gyorgi, A. (1929) J. Physiol. 68, 213–237.
Sattin, A. and Rail, T. W. (1970) The effect of adenosine and adenine nucleotides on the cyclic adenosine-3′,5′-phosphate content of guinea pig cerebral cortex slices. Mol. Pharmacol. 6, 13–23.
van Calker, D., Muller, M., and Hamprecht, B. (1979) Adenosine regulates, via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33, 999–1005.
Londos, C., Cooper, D. M. F., and Wolff, J. (1980) Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA 77, 2551–2554.
Tucker, A. L. and Linden, J. (1993) Cloned receptors and cardiovascular responses to adenosine. Cardiovasc. Res. 27, 62–67.
Revan, S., Montesinos, M. C., Naime, D., Landau, S., and Cronstein, B. N. (1996) Adenosine A2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J. Biol Chem. 271, 17,114–17,118.
Sexl, V., Mancusi, G., Baumgartner-Parzer, S., Schutz, W., and Freissmuth, M. (1995) Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors. Br. J. Pharmacol 114, 1577–1586.
Sexl, V., Mancusi, G., Holler, C., Gloria-Maercker, E., Schutz, W., and Freissmuth, M. (1997) Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J. Biol. Chem. 212, 5792–5799.
Marone, G., Thomas, L., and Lichtenstein, L. (1980) The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes. J. Immunol 125, 2277–2283.
Cronstein, B. N., Kramer, S. B., Weissmann, G., and Hirschhorn, R. (1983) Adenosine: a physiological modulator of Superoxide anion generation by human neutrophils. J. Exp. Med. 58, 1160–1177.
Cronstein, B. N., Rosenstein, E. D., Kramer, S. B., Weissmann, G., and Hirschhorn, R. (1985) Adenosine: a physiologic modulator of Superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J. Immunol 135, 1366–1371.
Roberts, P. A., Newby, A. C., Hallett, M. B., and Campbell, A. K. (1985) Inhibition by adenosine of reactive oxygen metabolite production by human polymorphonuclear leucocytes. Biochem. J. 227, 669–674.
Burkey, T. H. and Webster, R. O. (1993) Adenosine inhibits fMLP-stimulated adherence and Superoxide anion generation by human neutrophils at an early step in signal transduction. Biochim. Biophys. Acta 1175(3), 312–318.
Axtell, R. A., Sandborg, R. R., Smolen, J. E., Ward, P. A., and Boxer, L. A. (1990) Exposure of human neutrophils to exogenous nucleotides causes elevation in intracellular calcium, transmembrane calcium fluxes, and an alteration of a cytosolic factor resulting in enhanced Superoxide production in response to FMLP and arachidonic acid. Blood 75, 1324–1332.
Basford, R. E., Clark, R. L., Stiller, R. A., Kaplan, S. S., Kuhns, D. B., and Rinaldo, J. E. (1990) Endothelial cells inhibit receptor-mediated Superoxide anion production by human polymorphonuclear leukocytes via a soluble inhibitor. Am. J. Respir. Cell Mol. Biol. 2, 235–243.
de la Harpe, J. and Nathan, C. F. (1989) Adenosine regulates the respiratory burst of cytokine-triggered human neutrophils adherent to biologic surfaces. J. Immunol. 143, 596–602.
Currie, M. S., Rao, K. M., Padmanabhan, J., Jones, A., Crawford, J., and Cohen, H. J. (1990) Stimulus-specific effects of pentoxifylline on neutrophil CR3 expression, degranulation, and Superoxide production. J. Leukoc. Biol. 47, 244–250.
Günther, G. R. and Herring, M. B. (1991) Inhibition of neutrophil Superoxide production by adenosine released from vascular endothelial cells. Ann. Vascular Surg. 5, 325–330.
Nielson, C. P. and Vestal, R. E. (1989) Effects of adenosine on polymorphonuclear leucocyte function, cyclic 3′:5′-adenosine monophosphate, and inkacellular calcium. Br. J. Pharmacol. 97, 882–888.
Kaneko, M., Suzuki, K., Furui, H., Takagi, K., and Satake, T. (1990) Comparison of theophyl-line and enprotylline effects on human neutrophil Superoxide production. Clin. Exper. Pharmacol. Physiol. 17, 849–859.
McGarrity, S. T., Stephenson, A. H., and Webster, R. O. (1989) Regulation of human neutrophil functions by adenine nucleotides. J. Immunol. 142, 1986–1994.
Sipka, S., Szentmiklosi, A. J., Nagy, A., Taskov, V., and Szegedi, G. (1989) Inhibition of the zymosan-induced chemiluminescence of human phagocytes by adenosine, polyadenylic acid and agents influencing adenosine metabolism. Allergol. Immunopathol. 17, 209–212.
Thiel, M. and Bardenheuer, H. (1992) Regulation of oxygen radical production of human polymorphonuclear leukocytes by adenosine: The role of calcium. Pflugers Arch.—Eur. J. Physiol. 420, 522–528.
Cronstein, B. N., Duguma, L., Nicholls, D., Hutchison, A., and Williams, M. (1990) The adenosine/neutrophil paradox resolved: Human neutrophils possess both Al and A2 receptors which promote chemotaxis and inhibit O2 − generation, respectively. J. Clin. Invest. 85, 1150–1157.
van Calker, D., Steber, R., Klotz, K. N., and Greil, W. (1991) Carbamazepine distinguishes between adenosine receptors that mediate different second messenger responses. Eur. J. Pharmacol. 206, 285–290.
Fredholm, B. B., Zhang, Y., and van der Ploeg, I. (1996) Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes. Naunyn-Schmiedebergs Arch. Pharmacol. 354(3), 262–267.
Cronstein, B. N., Kramer, S. B., Rosenstein, E. D., Korchak, H. M., Weissmann, G., and Hirschhorn, R. (1988) Occupancy of adenosine receptors raises cyclic AMP alone and in synergy with occupancy of chemoattractant receptors and inhibits membrane depolarization. Biochem. J. 252, 709–715.
Grinstein, S. and Furuya, W. (1986) Cytoplasmic pH regulation in activated human neutrophils: Effects of adenosine and pertussis toxin on Na+/H+ exchange and metabolic acidification. Biochim. Biophys. Acta. 889, 301–309.
Walker, B. A. M., Cunningham, T. W., Freyer, D. R., Todd, R. F. III, Johnson, K. J., and Ward, P. A. (1989) Regulation of Superoxide responses of human neutrophils by adenine compounds: independence of requirement for cytoplasmic granules. Lab. Invest. 61, 515–521.
Bouma, M. G., Jeunhomme, T. M. M. A., Boyle, D. L., Dentener, M. A., Voitenok, N. N., van den Wildenberg, F. A. J. M., and Buurman, W. A. (1997) Adenosine inhibits neutrophil degranulation in activated human whole blood: Involvement of adenosine A2 and A3 receptors. J. Immunol. 158, 5400–5408.
Richter, J. (1992) Effect of adenosine analogues and cAMP-raising agents on TNF, GM-CSF-, and chemotactic peptide-induced degranulation in single adherent neutrophils. J. Leukoc. Biol. 51, 270–275.
Schmeichel, C. J. and Thomas, L. L. (1987) Methylxanthine bronchodilators potentiate multiple human neutrophil functions. J. Immunol. 138, 1896–1903.
Salmon, J. E. and Cronstein, B. N. (1990) Fcgamma receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy: A1 receptors are stimulatory and A2 receptors are inhibitory. J. Immunol. 145, 2235–2240.
Cronstein, B. N., Levin, R. I., Philips, M. R., Hirschhorn, R., Abramson, S. B., and Weissmann, G. (1992) Neutrophil adherence to endotheliurn is enhanced via adenosine Al receptors and inhibited via adenosine A2 receptors. J. Immunol. 148, 2201–2206.
Zalavary, S., Stendahl, O., and Bengtsson, T. (1994) The role of cyclic AMP, calcium and filamentous actin in adenosine modulation of Fc receptor-mediated phagocytosis in human neutrophils. Biochim. Biophys. Acta 1222, 249–256.
Firestein, G. S., Bullough, D. A., Erion, M. D., Jimenez, R., Ramirez-Weinhouse, M., Barankiewicz, J., Smith, C. W., Gruber, H. E., and Mullane, K. M. (1995) Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor: the role of selectins. J. Immunol. 154, 326–334.
Wollner, A., Wollner, S., and Smith, J. B. (1993) Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (CDllb/CD18) expression on FMLP-stimulated neutrophils. Am. J. Resp. Cell Mol. Biol. 9, 179–185.
Thiel, M., Chambers, J. D., Chouker, A., Fischer, S., Zourelidis, C., Bardenheuer, H. J., Arfors, K. E., and Peter, K. (1996) Effect of adenosine on the expression of beta(2) integrins and L-selectin of human polymorphonuclear leukocytes in vitro. J. Leukoc. Biol. 59(5), 671–682.
Krump, E., Lemay, G., and Borgeat, P. (1996) Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo. Brit. J. Pharm. 117, 1639–1644.
Thiel, M. and Chouker, A. (1995) Acting via A2 receptors, adenosine inhibits the production of tumor necrosis factor-alpha of endotoxin-stimulated human polymorphonuclear leukocytes. J. Lab. Clin. Med. 126(3), 275–282.
Boisseau, M. R., Pruvost, A., Renard, M., Closse, C., Belloc, F., Seigneur, M., and Maurel, A. (1996) Effect of buflomedil on the neutrophil-endothelial cell interaction under inflammatory and hypoxia conditions. Haemostasis 26(Suppl. 4), 182–188.
Zhao, Z. Q., Sato, H., Williams, M. W., Fernandez, A. Z., and Vinten-Johansen, J. (1996) Adenosine A2-receptor activation inhibits neukophil-mediated injury to coronary endothelium. Am. J. Physiol. 271(4 Pt. 2), H1456–H1464.
Minamino, T., Kitakaze, M., Node, K., Funaya, H., Inoue, M., Hori, M., and Kamada, T. (1996) Adenosine inhibits leukocyte-induced vasoconstriction. Am. J. Physiol. 271(6 Pt. 2), H2622–H2628.
Jordan, J. E., Zhao, Z. Q., Sato, H., Taft, S., and Vinten-Johansen, J. (1997) Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, super-oxide generation and coronary endothelial adherence. J. Pharmacol Exp. Ther. 280(1), 301–309.
Vinten-Johansen, J., Zhao, Z. Q., and Sato, H. (1995) Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy. Ann. Thorac. Surg. 60(3), 852–857.
Bullough, D. A., Magill, M. J., Firestein, G. S., and Mullane, K. M. (1995) Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes. J. Immunol. 155(5), 2579–2586.
Walker, B. A., Rocchini, C., Boone, R. H., Ip, S., and Jacobson, M. A. (1997) Adenosine A2α receptor activation delays apoptosis in human neutrophils. J. Immunol 158(6), 2926–2931.
Iannone, M. A., Reynolds-Vaughn, R., Wolberg, G., and Zimmerman, T. P. (1985) Human neutrophils possess adenosine A2 receptors. Fed. Proc. 44, 580.
Iannone, M. A., Wolberg, G., and Zimmerman, T. P. (1989) Chemotactic peptide induces cAMP elevation in human neutrophils by amplification of the adenylate cyclase response to endogenously produced adenosine. J. Biol. Chem. 264, 20,177–20,180.
Cronstein, B. N., Haines, K. A., Kolasinski, S. L., and Reibman, J. (1992) Occupancy of G-alpha s-linked receptors uncouples chemoattractant receptors from their stimulus-transduction mechanisms in the neutrophil. Blood 80, 1052–1057.
Revan, S., Montesinos, M. C., Naime, D., Landau, S., and Cronstem, B. N. (1996) Adenosine A2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J. Biol Chem. 271(29), 17,114–17,118.
Walker, B. A. M., Hagenlocker, B. E., Douglas, V. K., and Ward, P. A. (1990) Effects of adenosine on inositol 1,4,5-trisphosphate formation and intracellular calcium changes in formylmet-leu-phe-stimulated human neutrophils. J. Leuk. Biol. 48, 281–283.
Cronstein, B. N. and Haines, K. A. (1992) Adenosine A2 receptor occupancy does not affect “triggering” but inhibits “activation” of human neutrophils by a mechanism independent of actin filament formation. Biochem. J. 281, 631–635.
Cronstein, B. N., Haines, K. A., Kolasinski, S. L., and Reibman, J. (1991) Gs linked receptors (Beta-adrenergic and adenosine A2) uncouple chemoattractant receptors from G proteins. Clin. Res. 39, 343A.
Burkey, T. H. and Webster, R. O. (1993) Adenosine inhibits fMLP-stimulated adherence and Superoxide anion generation by human neutrophils at an early step in signal transduction. Biochim. Biophys. Acta 1175, 312–318.
Eppell, B. A., Newell, A. M., and Brown, E. J. (1989) Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. J. Immunol. 143, 4141–4145.
Salmon, J. E., Brownlie, C., Brogle, N., Edberg, J. C., Chen, B.-X., and Erlanger, B. F. (1993) Human mononuclear phagocytes express adenosine A1 receptors: a novel mechanism for differential regulation of Fc-gamma receptor function. J. Immunol. 151, 2775–2865.
Elliott, K. R. F., Stevenson, H. C., Miller, P. J., and Leonard, E. J. (1986) Synergistic action of adenosine and Fmet-leu-phe in raising cyclic AMP content of purified human monocytes. Biochem. Biophys. Res. Commun. 138, 1376–1382.
Leonard, E. J., Shenai, A., and Skeel, A. (1987) Dynamics of chemotactic peptideinduced superoxide generation by human monocytes. Inflammation 11, 229–240.
Hasko, G., Szabo, C., Nemeth, Z. H., Kvetan, V., Pastores, S. M., and Vizi, E. S. (1996) Adenosine receptor agonists differentially regulate IL-10, TNF-a, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157, 4634–4640.
Hon, W. M., Moochhala, S., and Khoo, H. E. (1997) Adenosine and its receptor agonists potentiate nitric oxide synthase expression induced by lipopolysaccharide in RAW 264.7 murine macrophages. Life Sci. 60(16), 1327–1335.
Merrill, J. T., Shen, C., Schreibman, D., Coffey, D., Zakharenko, O., Fisher, R., Lahita, R. G., Salmon, J., and Cronstein, B. N. (1997) Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arth. Rheum. 40, 1308–1315.
Lappin, D. and Whaley, K. (1984) Adenosine A2 receptors on human monocytes modulate C2 production. Clin. Exp. Immunol. 57, 454–460.
Hasday, J. D. and Sitrin, R. G. (1987) Adenosine receptors on rabbit alveolar macrophages: binding characteristics and effects on cellular function. J. Lab. Clin. Med. 110, 264–273.
Colli, S. and Tremoli, E. (1991) Multiple effects of dipyridamole on neutrophils and mononuclear leukocytes: adenosine-dependent and adenosine-independent mechanisms. J. Lab. Clin. Med. 118, 136–145.
Prabhakar, U., Brooks, D. P., Lipshlitz, D., and Esser, K. M. (1995) Inhibition of LPS-induced TNF alpha production in human monocytes by adenosine (A2) receptor selective agonists. Int. J. Immunopharmacol. 17(3), 221–224.
Sajjadi, F. G., Takabayashi, K., Foster, A. C., Domingo, R. C., and Firestein, G. S. (1996) Inhibition of TNFa expression by adenosine: role of A3 adenosine receptors. J. Immunol. 156, 3435–3442.
Parmely, M. J., Zhou, W-W, Edwards, C. K. III, Borcherding, D. R., Silverstein, R., and Morrison, D. C. (1993) Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J. Immunol. 151, 389–396.
Le Vraux, V., Chen, Y. L., Masson, I., De Sousa, M., Giroud, J. P., Florentin, I., and Chauvelot-Moachon, L. (1993) Inhibition of human monocyte TNF production by adenosine receptor agonists. Life Sci. 52(24), 1917–1924.
Bouma, M. G., Stad, R. K., van den Wildenberg, F. A. J. M., and Buurman, W. A. (1994) Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153, 4159–4168.
Bowlin, T. L., McWhinney, C. D., Borcherding, D. R., Edwards, C. K., Hoffman, P. F., Watts, L., and Wolos, J. A. (1995) Inhibition of NFkB nuclear translocation and TNFa gene expression by a novel adenosine A3 receptor agonist. Arth. Rheum. 38, S401.
McWhinney, C. D., Dudley, M. W., Bowlin, T. L., Peet, N. R., Schook, L., Bradshaw, M., De, M., Borcherding, D. R., and Edwards, C. K., III (1996) Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis-a. Eur. J. Pharm. 310, 209–216.
Le Moine, O., Stordeur, P., Schandene, L., Marchant, A., de Groote, D., Goldman, M., and Deviere, J. (1996) Adenosine enhances IL-10 secretion by human monocytes. J. Immunol. 156, 4408–4414.
Walker, B. A. (1996) Effects of adenosine on guinea pig pulmonary eosinophils. Inflammation 20(1), 11–21.
Kohno, Y., Ji, X., Mawhorter, S. D., Koshiba, M., and Jacobson, K. A. (1996) Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 88(9), 3569–3574.
Marquardt, D. L., Parker, C. W., and Sullivan, T. J. (1978) Potentiation of mast cell mediator release by adenosine. J. Immunol. 120, 871–878.
Holgate, S. T., Church, M. K., and Polosa, R. (1991) Adenosine: a positive modulator of airway inflammation in asthma. Ann. NY Acad. Sci. 629, 227–236.
Hannon, J. P., Pfannkuche, H. J., and Fozard, J. R. (1995) A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br. J. Pharmacol. 115(6), 945–952.
Ali, H., Choi, O. H., Fraundorfer, P. F., Yamada, K., Gonzaga, H. M., and Beaven, M. A. (1996) Sustained activation of phospholipase D via adenosine A3 receptors is associated with enhancement of antigen-and Ca(2+)-ionophore-induced secretion in a rat mast cell line. J. Pharmacol. Exp. Ther. 276(2), 837–845.
Fozard, J. R., Pfannkuche, H. J., and Schuurman, H. J. (1996) Mast cell degranulation following adenosine A3 receptor activation in rats. Eur. J. Pharmacol. 298(3), 293–297.
Shepherd, R. K., Linden, J., and Duling, B. R. (1996) Adenosine-induced vasoconstriction in vivo: role of the mast eel] and A3 adenosine receptor. Circulation Res. 78(4), 627–634.
Meade, C. J., Mierau, J., Leon, I., and Ensinger, H. A. (1996) In vivo role of the adeno sine A3 receptor: N6-2-(4-aminophenyl)ethyladeno sine induces broncho spasm in BDE rats by a neurally mediated mechanism involving cells resembling mast cells. J. Pharmacol. Exper. Ther. 279(3), 1148–1156.
Feoktistov, I. and Biaggioni, I. (1995) Adenosine A2b receptors evoke interleukin8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J. Clin. Invest. 96(4), 1979–1986.
Ethier, M. F., Chander, V., and Dobson, J. G., Jr. (1993) Adenosine stimulates proliferation of human endothelial cells in culture. Am. J. Physiol. 265, H131–H138.
Takagi, H., King, G. L., Robinson, G. S., Ferrara, N., and Aiello, L. P. (1996) Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest. Ophthalmol. Vis. Sci. 37, 2165–2176.
Takagi, H., King, G. L., Ferrara, N., and Aiello, L. P. (1996) Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest. Ophthalmol. Vis. Sci. 37, 1311–1321.
Schiele, J. O. and Schwabe, U. (1994) Characterization of the adenosine receptor in microvascular coronary endothelial cells. Eur. J. Pharm. 269, 51–58.
Pillinger, M. H., Feoktistov, A. S., Capodici, C., Solitar, B., Levy, J., Oei, T. T., and Philips, M. R. (1996) Mitogen-activated protein kinase in neutrophils and enucleate neutrophil cytoplasts: evidence for regulation of cell—cell adhesion. J. Biol. Chem. 271(20), 12049–56.
Bouma, M. G., van den Wildenberg, F. A. J. M., and Buurman, W. A. (1996) Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am. J. Physiol. 39, C522–C529.
Rosengren, S., Arfors, K. E., and Proctor, K. G. (1991) Potentiation of leukotriene B4-mediated inflammatory response by the adenosine antagonist, 8-phenyl theophylline. Intl. J. Microcirc. Clin. Exp. 10, 345–357.
Becker, B. F., Zahler, S., Raschke, P., Schwartz, L. M., Beblo, S., Schrodl, W., and Kiesl, D. (1992) Adenosine enhances neutrophil sticking in the coronary system: A novel mechanism contributing to cardiac reperfusion damage. Pharm. Pharmacol. Lett. 2, 8–11.
Schwartz, L. M., Raschke, P., Becker, B. F., and Gerlach, E. (1993) Adenosine contributes to neutrophil-mediated loss of myocardial function in post-ischemic guinea-pig hearts. J. Mol Cell. Cardiol. 25, 927–938.
Zahler, S., Becker, B. F., Raschke, R., and Gerlach, E. (1994) Stimulation of endothelial adenosine A1 receptors enhances adhesion of neutrophils in the intact guinea pig coronary system. Cardiovasc. Res. 28, 1366–1372.
Raschke, P. and Becker, B. F. (1995) Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischemia. Cardiovasc. Res. 29, 569–576.
Schrier, D. J., Lesch, M. E., Wright, C. D., and Gilbertsen, R. B. (1990) The antiinflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats. J. Immunol 145, 1874–1879.
Lesch, M. E., Ferin, M. A., Wright, C. D., and Schrier, D. J. (1991) The effects of (R)-N-(l-methyl-2-phenylethyl) adenosine (L-PIA), a standard A1-selective adenosine agonist on rat acute models of inflammation and neutrophil function. Agents Actions 34, 25–27.
Bong, G. W., Rosengren, S., and Firestein, G. S. (1996) Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation: the role of N-methyl-D-aspartate receptors. J. Clin. Invest. 98, 2779–2785.
Green, P. G., Basbaum, A. I., Helms, C., and Levine, J. D. (1991) Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat. Proc. Natl. Acad. Sci. USA 88, 4162–4165.
Moser, G. H., Schrader, J., and Deussen, A. (1989) Turnover of adenosine in plasma of human and dog blood. Am. J. Physiol. 256, C799–C806.
Rosengren, S., Bong, G. W., and Firestein, G. S. (1995) Anti-inflammatory effects of an adenosine kinase inhibitor: decreased neutrophil accumulation and vascular leakage. J. Immunol. 154, 5444–5451.
Cronstein, B. N., Naime, D., and Firestein, G. S. (1995) The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arth. Rheum. 38, 1040–1045.
Firestein, G. S., Boyle, D., Bullough, D. A., Gruber, H. E., Sajjadi, F. G., Montag, A., Sambol, B., and Mullane, K. M. (1994) Protective effect of an adenosine kinase inhibitor in septic shock. J. Immunol. 152(12), 5853–5859.
Cronstein, B. N., Eberle, M. A., Gruber, H. E., and Levin, R. I. (1991) Methotrexate inhibits neutrophil-function by stimulating adenosine release from connective tissue cells. Proc. Natl. Acad. Sci. USA 88, 2441–2445.
Cronstein, B. N., Naime, D., and Ostad, E. (1993) The antiinflammatory mechanism of methotrexate: Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92, 2675–2682.
Gadangi, P., Longaker, M., Naime, D., Levin, R. I., Recht, P. A., Montesinos, M. C., Buckley, M. T., Carlin, G., and Cronstein, B. N. (1996) The antiinflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J. Immunol. 156, 1937–1941.
Morabito, L., Montesinos, M. C., Schreibman, D. M., Baiter, L., Thompson, L. F., Resta, R., and Cronstein, B. N. (1997) Methotrexate and sulfasalazine promote adenosine release: the role of ecto-51 nucleotidase. J. Invest. Med. 45, 241A.
Yap, J. S., Montesinos, M. C., McCrary, C. T., and Cronstein, B. N. (1997) Theophylline reverses the effect of methotrexate on adjuvant arthritis: evidence that adenosine mediates the anti-inflammatory effects of methotrexate. Arth. Rheum. 40, 598.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cronstein, B.N. (1999). Adenosine and Its Receptors During Inflammation. In: Serhan, C.N., Ward, P.A. (eds) Molecular and Cellular Basis of Inflammation. Current Inflammation Research. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-253-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-59259-253-1_12
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-089-2
Online ISBN: 978-1-59259-253-1
eBook Packages: Springer Book Archive